Achilles tendinosis results from a chronic degenerative process within the tendon. Topaz micro-debridement aims to restore the degenerate micro-architecture within the tendon reducing painful symptoms experienced by patients. Topaz micro-debridement has been used to successfully treat upper limb tendinopathies but its application to tendinopathies of the foot and ankle is relatively new. This study aims to assess the functional outcomes following topaz radiofrequency micro-debridement for Achilles tendinosis. All cases of topaz micro-debridement for Achilles tendinosis were identified from hospital records spanning a five year period. VISA-A assessment questionnaires were sent to these patients to assess the patients functional status pre and post-surgery. Patients were asked to comment on their overall satisfaction and to report any complications they had experienced. Eight responses were received and included in analysis. Hospital records and imaging results were investigated for those that responded.Introduction
Materials/Methods
Appropriate consenting is part of good medical practice and is a medico-legal necessity for invasive procedures. The BOA recently created generic consent forms covering the relevant complications for orthopaedic procedures, thus providing a standard for all orthopaedic consent. This study aims to assess the quality of consent in orthopaedic practice. The most common elective and trauma procedures were identified over a one year period and consent forms for all patients undergoing these procedures were assessed against BOA ortho-consent forms. Data was compiled from elective total hip replacements (THR) and trauma ankle open reduction and internal fixations (ORIF), and analysed in excel.Introduction
Materials/Methods
‘VTE disease is the new MRSA’, with much attention received in the media and the political world. Following the 2010 NICE guidelines all patients admitted to hospital should have VTE prophylaxis considered and a formal VTE risk assessment done with documentation and review in a 24 hour period. We carried out a completed audit cycle to identify our adherence to these guidelines and introduced a novel method to ensure compliance. An audit of 400 patients admitted to the orthopaedic department was carried out with review of case notes. Three key parameters were investigated: Firstly the compliance of carrying out a risk assessment for VTE disease with correct documentation, secondly investigating how many patients got re-assessed in 24 hours and finally if patients received appropriate VTE prophylaxis. The data was re-audited following the introduction of a new drug chart with a box section for VTE risk assessment and prophylaxis on the chart itself.Introduction
Materials/Methods
